Literature DB >> 18692581

Paracrine action of HO-1-modified mesenchymal stem cells mediates cardiac protection and functional improvement.

Bin Zeng1, Xiaofeng Ren, Guosheng Lin, Chengang Zhu, Honglei Chen, Jiechao Yin, Hong Jiang, Bo Yang, Danhua Ding.   

Abstract

The aim has been to determine whether the supernatants of mesenchymal stem cells (MSCs) transfected with adenovirus carrying human heme oxygenase-1 (hHO-1) gene protect cardiomyocytes from ischemic injury. We have found that hHO-1 infected MSCs (hHO-1-MSCs) increased expression of hHO-1 protein. Apoptosis of cultured hHO-1-MSCs exposed to hypoxia was suppressed. Several cytokines, including HGF, bFGF, TGF-beta, VEGF and IL-1beta, were produced by hHO-1-MSCs, some being significantly enhanced under hypoxia stimulation. Meanwhile, those cytokines reduced caspase-3 level and activity in cultured adult rat ventricular cardiomyocytes (ARVCs) exposed to hypoxia. Supernatants obtained from hHO-1-MSCs improved left ventricular function, limited myocardial infarct size, increased microvessel density, and inhibited apoptosis of cardiomyocytes in rat myocardial infarction. It can be concluded hHO-1-modified MSCs prevent myocardial cell injury via secretion of paracrine-acting mediators.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18692581     DOI: 10.1016/j.cellbi.2008.07.010

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  20 in total

Review 1.  Genetic engineering of mesenchymal stem cells and its application in human disease therapy.

Authors:  Conrad P Hodgkinson; José A Gomez; Maria Mirotsou; Victor J Dzau
Journal:  Hum Gene Ther       Date:  2010-10-22       Impact factor: 5.695

2.  Paracrine effects of mesenchymal stem cells in cisplatin-induced renal injury require heme oxygenase-1.

Authors:  Abolfazl Zarjou; Junghyun Kim; Amie M Traylor; Paul W Sanders; József Balla; Anupam Agarwal; Lisa M Curtis
Journal:  Am J Physiol Renal Physiol       Date:  2010-11-03

Review 3.  Strategies for improving the efficacy of bioengineered bone constructs: a perspective.

Authors:  H Petite; K Vandamme; L Monfoulet; D Logeart-Avramoglou
Journal:  Osteoporos Int       Date:  2011-06       Impact factor: 4.507

Review 4.  Use of mesenchymal stem cells for therapy of cardiac disease.

Authors:  Vasileios Karantalis; Joshua M Hare
Journal:  Circ Res       Date:  2015-04-10       Impact factor: 17.367

5.  Stem Cell Therapy for Myocardial Infarction 2001-2013 Revisited.

Authors:  Christoph Edlinger; Catharina Schreiber; Bernhard Wernly; Alexandra Anker; Katja Ruzicka; Christian Jung; Uta C Hoppe; Michael Lichtenauer
Journal:  Stem Cell Rev Rep       Date:  2015-10       Impact factor: 5.739

6.  High glucose concentration in cell culture medium does not acutely affect human mesenchymal stem cell growth factor production or proliferation.

Authors:  Brent R Weil; Aaron M Abarbanell; Jeremy L Herrmann; Yue Wang; Daniel R Meldrum
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-04-22       Impact factor: 3.619

7.  Genetically Engineered Mesenchymal Stem Cells Influence Gene Expression in Donor Cardiomyocytes and the Recipient Heart.

Authors:  Mary Kearns-Jonker; Wangde Dai; Mirja Gunthart; Tania Fuentes; Hsiao-Yun Yeh; Paul Gerczuk; Martin Pera; Christine Mummery; Robert A Kloner
Journal:  J Stem Cell Res Ther       Date:  2012-06-07

Review 8.  Extrinsic and Intrinsic Mechanisms by Which Mesenchymal Stem Cells Suppress the Immune System.

Authors:  Vivien J Coulson-Thomas; Yvette M Coulson-Thomas; Tarsis F Gesteira; Winston W-Y Kao
Journal:  Ocul Surf       Date:  2016-01-12       Impact factor: 5.033

Review 9.  Heme Oxygenase-1 and Carbon Monoxide in the Heart: The Balancing Act Between Danger Signaling and Pro-Survival.

Authors:  Leo E Otterbein; Roberta Foresti; Roberto Motterlini
Journal:  Circ Res       Date:  2016-06-10       Impact factor: 17.367

10.  Over-expression of HO-1 on mesenchymal stem cells promotes angiogenesis and improves myocardial function in infarcted myocardium.

Authors:  Bin Zeng; Guosheng Lin; Xiaofeng Ren; Yan Zhang; Honglei Chen
Journal:  J Biomed Sci       Date:  2010-10-07       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.